1-3 of 3
Leonel Gallegos, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemtuzumab Ozogamicin In Combination With Vorinostat and Azacitidine In Older Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML): Final Results From A Phase 1/2 Study

Roland B. Walter, MD, PhD, Bruno C. Medeiros, MD, Kelda M. Gardner, PA-C, Kaysey F. Orlowski, Leonel Gallegos, MD, Bart L Scott, MD, Paul C. Hendrie, MD, PhD, Elihu H. Estey, MD
Journal: Blood
Blood (2013) 122 (21): 3936.
https://doi.org/10.1182/blood.V122.21.3936.3936
Published: 2013
Journal Articles

Azacitidine Plus Lenalidomide for Untreated AML Patients Ineligible for Conventional Chemotherapy

Daniel A Pollyea, MD, James L. Zehnder, Steven Coutre, MD, Jason Gotlib, Leonel Gallegos, MD, Peter Greenberg, MD, Bing Zhang, MD, MS, Michaela Liedtke, MD, Ross L. Levine, Bruno C. Medeiros, MD
Journal: Blood
Blood (2012) 120 (21): 3575.
https://doi.org/10.1182/blood.V120.21.3575.3575
Published: 2012
Journal Articles

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)

Daniel A Pollyea, MD, Holbrook E Kohrt, MD, Leonel Gallegos, MD, Caroline Berube, MD, Steven Coutre, MD, Jason Gotlib, M.D., M.S., Michaela Liedtke, MD, Beverly S. Mitchell, MD, Bruno C. Medeiros, MD
Journal: Blood
Blood (2010) 116 (21): 3288.
https://doi.org/10.1182/blood.V116.21.3288.3288
Published: 2010